1.Antepartal insulin-like growth factor concentrations indicating differences in the metabolic adaptive capacity of dairy cows.
Marion PIECHOTTA ; Lars HOLZHAUSEN ; Marcelo Gil ARAUJO ; Maike HEPPELMANN ; Anja SIPKA ; Chistiane PFARRER ; Hans Joachim SCHUBERTH ; Heinrich BOLLWEIN
Journal of Veterinary Science 2014;15(3):343-352
Cows with different Insulin-like Growth Factor-I (IGF-I) concentrations showed comparable expression levels of hepatic growth hormone receptor (GHR). Suppressor of cytokine signaling 2 (SOCS2), could be responsible for additional inhibition of the GHR signal cascade. The aims were to monitor cows with high or low antepartal IGF-I concentrations (IGF-I(high) or IGF-I(low)), evaluate the interrelationships of endocrine endpoints, and measure hepatic SOCS2 expression. Dairy cows (n = 20) were selected (240 to 254 days after artificial insemination (AI)). Blood samples were drawn daily (day -17 until calving) and IGF-I, GH, insulin, thyroid hormones, estradiol, and progesterone concentrations were measured. Liver biopsies were taken (day 264 +/- 1 after AI and postpartum) to measure mRNA expression (IGF-I, IGFBP-2, IGFBP-3, IGFBP-4, acid labile subunit (ALS), SOCS2, deiodinase1, GHR1A). IGF-I concentrations in the two groups were different (p < 0.0001). However, GH concentrations and GHR1A mRNA expression were comparable (p > 0.05). Thyroxine levels and ALS expression were higher in the IGF-I(high) cows compared to IGF-I(low) cows. Estradiol concentration tended to be greater in the IGF-I(low) group (p = 0.06). It was hypothesized that low IGF-I levels are associated with enhanced SOCS2 expression although this could not be decisively confirmed by the present study.
Animals
;
Cattle
;
Estradiol/blood
;
Female
;
Growth Hormone/blood
;
Insulin/blood
;
Insulin-Like Growth Factor Binding Protein 2/analysis
;
Insulin-Like Growth Factor Binding Protein 3/analysis
;
Insulin-Like Growth Factor Binding Protein 4/analysis
;
Insulin-Like Growth Factor I/*analysis/physiology
;
Liver/chemistry
;
Pregnancy/metabolism/physiology
;
Pregnancy, Animal/*metabolism/physiology
;
Progesterone/blood
;
Suppressor of Cytokine Signaling Proteins/analysis
;
Thyroid Hormones/blood
2.Identification of serological biomarkers for diagnosis of rheumatoid arthritis using a protein array-based approach.
Yi Peng HAN ; Xiao Xi LU ; Wei Nan LAI ; Ren Ge LIANG ; Min YANG ; Qing Qing OUYANG
Journal of Southern Medical University 2022;42(5):733-739
OBJECTIVE:
To study the cytokine patterns in patients with rheumatoid arthritis (RA) and healthy individuals and identify candidate serum biomarkers for clinical diagnosis of RA.
METHODS:
This study was conducted among 59 patients diagnosed with RA in our hospital from 2015 to 2019 with 46 age- and gender-matched healthy subjects who received regular physical examinations in our hospital as the control group. Serological autoimmune profiles of 5 RA patients and 5 healthy control subjects were obtained from human cytokine microarrays. We selected 4 differentially expressed cytokines (LIMPII, ROBO3, Periostin and IGFBP-4) and 2 soluble cytokine receptors of interest (2B4 and Tie-2) and examined their serum levels using enzyme-linked immunosorbent assay in 54 RA patients and 41 healthy control subjects. Spearman correlation test was performed to assess the correlation of serum cytokine and soluble receptor expression levels with the clinical features including rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), disease activity score (DAS28) and health assessment questionnaire (HAQ). Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic capability of these cytokines.
RESULTS:
We identified 6 dysregulated cytokines and soluble receptors (2B4, LIMPII, Tie-2, ROBO3, periostin and IGFBP-4) in RA patients (P < 0.01). The serum levels of LIMPII, ROBO3 and periostin were significantly correlated with the disease activity indicators including RF (P < 0.001), CRP (P < 0.001), DAS28 (P < 0.001) and HAQ (P < 0.001) in RA patients. Among the 6 candidate cytokines, 2B4 showed the largest area under the curve (AUC) of 0.861 for RA diagnosis (P < 0.001), followed then by LIMPII, ROBO3, periostin, Tie-2 and IGFBP-4.
CONCLUSION
Serum levels of LIMPII, ROBO3 and periostin can be indicative of the disease activity of RA, and serum 2B4, LIMPII, periostin, ROBO3, IGFBP-4 and Tie-2 levels may serve as biomarkers for the diagnosis of RA.
Arthritis, Rheumatoid/diagnosis*
;
Biomarkers
;
C-Reactive Protein
;
Cytokines
;
Humans
;
Insulin-Like Growth Factor Binding Protein 4
;
Protein Array Analysis
;
Receptors, Cell Surface
3.Effect of 7-day gonadotropin-releasing hormone agonist protocol on IGF-II and IGFBP-4 levels in the follicular fluid.
Jianmei ZHANG ; Yanping LI ; Jing LIU ; Dong' e LIU ; Nenghui LIU ; Xianhua CHEN
Journal of Central South University(Medical Sciences) 2009;34(3):190-194
OBJECTIVE:
To explore the different effect of short 7-day gonadotropin releasing hormone agonist (GnRHa) protocol and GnRHa long protocol on the insulin-like growth factor II(IGF-II) and insulin-like growth factor binding protein-4 (IGFBP-4) levels in follicular fluid.
METHODS:
Eighty-eight infertile patients due to tubal factors were included in this study. They were randomly divided into a short 7-day GnRHa protocol group and a GnRHa long protocol group (n = 44). Follicular fluid was obtained from dominant follicles during oocyte retrieval. Levels of IGF-II and IGFBP-4 in the follicular fluid were detected by radioimmunoassay and enzyme-linked immunosorbent assay respectively.
RESULTS:
Duration of controlled ovarian stimulation was significantly shorter and the injected dosages of gonadotropin were significantly lower in the short 7-day protocol group. The differences in serum levels of estradiol and estradiol per mature follicle on the day of human chorionic gonadotropin injection between the two groups were not significant. The concentrations of IGF-II and IGFBP-4 in the follicular fluid of the short 7-day protocol group were significantly lower,while the difference of the ratio of IGF-II/IGFBP-4 between the two groups was not significant. Linear correlation analysis showed that IGF-II level in the follicular fluid was positively correlated to the total dose of gonadotropin.
CONCLUSION
The short 7-day and long GnRHa protocols may affect the concentrations of IGF-II and IGFBP-4 in the follicular fluid. However, changes of IGF-II and IGFBP-4 concentrations do not contribute to different clinical outcomes.
Embryo Transfer
;
Female
;
Fertilization in Vitro
;
methods
;
Follicular Fluid
;
chemistry
;
Gonadotropin-Releasing Hormone
;
administration & dosage
;
agonists
;
Humans
;
Insulin-Like Growth Factor Binding Protein 4
;
analysis
;
Insulin-Like Growth Factor II
;
analysis
;
Ovulation Induction
;
methods
4.A differential gene expression profiles by cDNA microarrays in endometrioid endometrial carcinoma: a preliminary study.
Min Ji CHUNG ; Eun Jung CHUNG ; Taek Hoo LEE ; Young Lae CHO ; Il Soo PARK ; Yoon Soon LEE
Korean Journal of Gynecologic Oncology 2007;18(3):219-226
OBJECTIVE: Endometrial carcinoma is the most common gynecological malignant disease in industrialized countries. However, the molecular bases for endometrial tumoriogenesis are not clearly elucidated. Our hypothesis is that there may be some difference in gene expression patterns between normal endometrium and endometrial cancer lesion. In this study, we analyzed the difference of gene expression profile with cDNA microarray. METHODS: Normal endometrial tissues and cancer lesions were gathered from three patient with endometrioid endometrial cancer. cDNA microarray technique (KNU 4.8K chip) was applied to screen the different gene expression profiles. RESULTS: Many genes such as interleukin-1 receptor-associated kinase 1 (IRAK1), bifunctional apoptosis regulator (BFAR), paraneoplastic antigen MA2 (PNMA2), zinc finger protein 257 (ZNF257), ras homolog gene family, member F (in filopodia) (ARHF), cell division cycle 27 (CDC27) were over-expressed in the endometrial cancer tissue. The genes were down-regulated in the endometrial cancer samples included fibronectin 1 (FN1), meiotic checkpoint regulator (MCPR), transforming growth factor beta-stimulated protein TSC-22 (TSC22), programmed cell death 4 (neoplastic transformation inhibitor) (PDCD4), transcript variant 2, matrix metalloproteinase 2 (MMP2), insulin-like growth factor binding protein 4 (IGFBP4), retinoblastoma binding protein 7 (RBBP7), insulin-like growth factor binding protein 3 (IGFBP3), downregulated in ovarian cancer 1 (DOC1). CONCLUSION: The result of this analysis supports the hypothesis that the endometrial cancer tissue has distinct gene expression profile from normal endometium. But, the vaildation of gene expression with RT-PCR and the further study are needed.
Apoptosis
;
Cell Cycle
;
Cell Death
;
Developed Countries
;
DNA, Complementary*
;
Endometrial Neoplasms*
;
Endometrium
;
Female
;
Fibronectins
;
Gene Expression*
;
Humans
;
Insulin-Like Growth Factor Binding Protein 3
;
Insulin-Like Growth Factor Binding Protein 4
;
Interleukin-1 Receptor-Associated Kinases
;
Matrix Metalloproteinase 2
;
Oligonucleotide Array Sequence Analysis*
;
Ovarian Neoplasms
;
Retinoblastoma-Binding Protein 7
;
Transcriptome*
;
Transforming Growth Factors
;
Zinc Fingers
5.Gene Alterations of Ovarian Cancer Cells Expressing Estrogen Receptors by Estrogen and Bisphenol A Using Microarray Analysis.
Kyung A HWANG ; Se Hyung PARK ; Bo Rim YI ; Kyung Chul CHOI
Laboratory Animal Research 2011;27(2):99-107
Since endocrine disrupting chemicals (EDCs) may interfere with the endocrine system(s) of our body and have an estrogenicity, we evaluated the effect(s) of bisphenol A (BPA) on the transcriptional levels of altered genes in estrogen receptor (ER)-positive BG-1 ovarian cancer cells by microarray and real-time polymerase-chain reaction. In this study, treatment with 17beta-estradiol (E2) or BPA increased mRNA levels of E2-responsive genes related to apoptosis, cancer and cell cycle, signal transduction and nucleic acid binding etc. In parallel with their microarray data, the mRNA levels of some altered genes including RAB31_MEMBER RAS ONCOGENE FAMILY (U59877), CYCLIN D1 (X59798), CYCLIN-DEPENDENT KINASE 4 (U37022), IGF-BINDING PROTEIN 4 (U20982), and ANTI-MULLERIAN HORMONE (NM_000479) were significantly induced by E2 or BPA in this cell model. These results indicate that BPA in parallel with E2 induced the transcriptional levels of E2-responsive genes in an estrogen receptor (ER)-positive BG-1 cells. In conclusion, these microarray and real-time polymerase-chain reaction results indicate that BPA, a potential weak estrogen, may have estrogenic effect by regulating E2-responsive genes in ER-positive BG-1 cells and BG-1 cells would be the best in vitro model to detect these estrogenic EDCs.
Anti-Mullerian Hormone
;
Apoptosis
;
Benzhydryl Compounds
;
Cell Cycle
;
Cyclin D1
;
Cyclin-Dependent Kinase 4
;
Endocrine Disruptors
;
Estrogens
;
Genes, ras
;
Humans
;
Insulin-Like Growth Factor Binding Protein 4
;
Microarray Analysis
;
Ovarian Neoplasms
;
Phenols
;
Receptors, Estrogen
;
RNA, Messenger
;
Signal Transduction
6.Growth impairment of primary chondrocyte cells by serum of rats with chronic renal failure.
Robert H MAK ; Stella L CHANG ; Youngmi Kim PAK
Experimental & Molecular Medicine 2004;36(3):243-250
Insulin-like growth factor (IGF)/IGF binding protein (IGFBP) abnormalities may be important in the pathogenesis of growth failure in chronic renal failure (CRF). We induced experimental CRF by 5/6 nephrectomy in Sprague Dawley rats (100 g) and observed for 2 weeks comparing with sham-operated pair-fed control rats (Sham- C). CRF rats gained 30% less height than Sham- C rats (P<0.01). Serum IGFBP profiles by Western ligand blot revealed that IGFBP4 was elevated two fold in CRF rats (P<0.01 vs. Sham-C). However, IGFBP4 mRNA levels in liver or skeletal muscle were not different in two groups. To determine if the increase of serum IGFBP4 in CRF retarded the growth of cartilage, epiphyseal chondrocytes were isolated from CRF or control rats and cultured in the presence of control or CRF rat sera. Incubation with 10% CRF serum reduced proliferations of normal chondrocytes and L6 rat skeletal muscle cells. In contrast, 10% CRF serum did not inhibit the growth of CRF chondrocytes. Rat sera from two groups were separated into two different fractions, high (>10 kDa, containing IGFBPs) and low (<10 kDa, containing free IGF) molecular weight fractions using a gel filtration column. Both fractions obtained from CRF sera decreased the growth of control chondrocytes up to 40% compared with those from control sera. We suggest that the pathogenesis of growth failure in CRF may be involved in the increase of circulating IGFBP4 as well as the unidentified small molecular weight uremic serum factors which block the growth of chondrocytes in growth plate.
Animals
;
Cell Proliferation
;
Cells, Cultured
;
Chondrocytes/*cytology/metabolism
;
Insulin-Like Growth Factor Binding Protein 4/analysis/*blood/genetics
;
Kidney Failure, Chronic/*blood/metabolism/physiopathology
;
Liver/chemistry
;
Male
;
Muscle, Skeletal/chemistry
;
RNA, Messenger/analysis/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Somatomedins/analysis/metabolism